(Q57224706)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

title

Poly[allylamine hydrochloride] (RenaGel): a noncalcemic phosphate binder for the treatment of hyperphosphatemia in chronic renal failure (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

author name string

G M Chertow

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

S K Burke

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J M Lazarus

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

K H Stenzel

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D Wombolt

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

D Goldberg

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

J V Bonventre

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

E Slatopolsky

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

language of work or name

English

0 references

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

American Journal of Kidney Diseases

31 October 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

volume

29

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

page(s)

66-71

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

Gastrointestinal absorption of aluminum from aluminum-containing antacids

31 October 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Bone disease and aluminum: pathogenic considerations

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Aluminum and the pathogenesis of dialysis encephalopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Calcium carbonate as a phosphate binder in patients with chronic renal failure undergoing dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Long-term effects of calcium carbonate and 2.5 mEq/liter calcium dialysate on mineral metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Calcium acetate, an effective phosphorus binder in patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Hypercalcaemia after oral calcium-carbonate therapy in patients on chronic haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Etiology of hypercalcemia in hemodialysis patients on calcium carbonate therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

The validity of a telephone-administered 24-hour dietary recall methodology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Review of methods and criteria for the evaluation of bioequivalence studies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

On the pathogenesis of hyperparathyroidism in chronic experimental renal insufficiency in the dog

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

The role of phosphorus restriction in the prevention of secondary hyperparathyroidism in chronic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Effect of dietary phosphorus on circulating concentrations of 1,25-dihydroxyvitamin D and immunoreactive parathyroid hormone in children with moderate renal insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

In advanced renal failure, dietary phosphorus restriction reverses hyperparathyroidism independent of changes in the levels of calcitriol

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Phosphorus restriction prevents parathyroid gland growth. High phosphorus directly stimulates PTH secretion in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Calcium and phosphorus fluxes during hemodialysis with low calcium dialysate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Minerals, vitamin D, and parathyroid hormone in continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

Mechanisms and treatment of dyslipidemia of renal diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990009-3

7 January 2021

10.1016/S0272-6386(97)90009-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9002531%20AND%20SRC:MED&resulttype=core&format=json

31 October 2019

1 reference